Mobile Devices as Educational Skin History Tools
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03419637 |
|
Recruitment Status :
Completed
First Posted : February 5, 2018
Last Update Posted : March 11, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Skin Cancer | Other: Mobile app | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 70 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Triple (Care Provider, Investigator, Outcomes Assessor) |
| Primary Purpose: | Supportive Care |
| Official Title: | Evaluating the Use of Mobile Devices as Educational Tools Regarding Skin History |
| Actual Study Start Date : | April 4, 2017 |
| Actual Primary Completion Date : | August 2, 2017 |
| Actual Study Completion Date : | December 31, 2018 |
| Arm | Intervention/treatment |
|---|---|
|
No Intervention: Control - Standard of Care
The standard of care consists of in-clinic counseling, informational handouts, and access to patient medical records
|
|
|
Experimental: Intervention - Mobile app
The mobile app, or app, is used to document before and after photos of the excised skin areas and to document related diagnoses. The app allows patients to view a skin history summary report and a reference on their skin findings and procedures.
|
Other: Mobile app
The mobile app, or app, is installed on the patient's mobile device and is used to document the surgical procedure with before and after photographs, including pre- and post-surgery diagnosis. The app allows patients to view a skin history summary report and a reference on their skin findings and procedures. |
- Understanding of recent skin excision - 3 weeks later [ Time Frame: 3 weeks ]After study enrollment, patients have one or more skin areas excised. They complete an in-clinic survey immediately after the excision and another survey 3 weeks later where they are asked questions regarding the clinic visit and the related excised skin areas and diagnoses. Understanding is assessed by comparing against the medical record to calculate the number/percent of correct responses.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Have an appointment in the Penn Dermatologic Surgery Clinic for removal of a skin area during the study enrollment period
- Possession of a mobile device running iOS with the study mobile app (intervention) successfully installed (assistance will be provided by research staff if needed)
Exclusion Criteria:
- Children or adolescents, or if the patient is court-ordered to attend residential alcohol or other drug treatment facilities and therefore considered prisoners
- Patients will also be excluded if they are incompetent to provide informed consent and HIPAA authorization.
- If the area being operated on is of the genitals or breasts
- If the area being operated on is of the face, and photos of the area cannot be cropped or the eyes cannot be covered sufficiently such that photos are non-identifying
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03419637
| United States, Pennsylvania | |
| University of Pennsylvania | |
| Philadelphia, Pennsylvania, United States, 19104 | |
| Principal Investigator: | Christopher Miller, MD | University of Pennsylvania |
| Responsible Party: | University of Pennsylvania |
| ClinicalTrials.gov Identifier: | NCT03419637 |
| Other Study ID Numbers: |
826558 |
| First Posted: | February 5, 2018 Key Record Dates |
| Last Update Posted: | March 11, 2019 |
| Last Verified: | March 2019 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Skin Neoplasms Neoplasms by Site Neoplasms Skin Diseases |

